Indeed, using an experimental design based on two independent cohorts, we showed that the dPCR assay was better than standard methods and was able to detect the main somatic EGFR alterations in DNA extracted from FFPE tumor samples with a diagnostic performance of 100%. Here, EGFR is linked to neoplasm.